A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
10/2002
10/17/2002	WO2002081646A2 Epitope sequences
10/17/2002	WO2002081634A2 Imaging nucleic acid delivery
10/17/2002	WO2002081628A2 Modulation of gene expression associated with inflammation proliferation and neurite outgrowth, using nucleic acid based technologies
10/17/2002	WO2002081625A2 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
10/17/2002	WO2002081621A2 Vaccine against the nile fever virus
10/17/2002	WO2002081518A2 Proteins, polynucleotides encoding them and methods of using the same
10/17/2002	WO2002081513A2 Disease-associated protein
10/17/2002	WO2002081510A2 Proteins, polynucleotides encoding them and methods of using the same
10/17/2002	WO2002081494A1 Oligonucleotide mediated inhibition of hepatitis b virus and hepatitis c virus replication
10/17/2002	WO2002081007A2 Methods of isolating blood components using a centrifuge and uses thereof
10/17/2002	WO2002080983A1 Enhanced dispersion of adenoviral vectors by fusogenic membrane glycoproteins
10/17/2002	WO2002080982A2 Nucleic acid mucosal immunization
10/17/2002	WO2002080981A2 Polynucleotide binding complexes comprising sterols and saponins
10/17/2002	WO2002080979A2 Conjugate of hydroxyalkyl starch and an active agent
10/17/2002	WO2002080977A1 Biodegradable carrier and method for preparation thereof
10/17/2002	WO2002080948A1 Compositions and methods for treating inflammation and related conditions
10/17/2002	WO2002080888A2 Estrogen receptor-related receptor alpha (err) agonist for inducing cartilage formation
10/17/2002	WO2002080851A2 Chimeric vaccines
10/17/2002	WO2002080849A2 Chemotherapeutic induction of egr-1 promoter activity
10/17/2002	WO2002080845A2 Novel eps8 compounds for therapy and diagnosis and methods for using same
10/17/2002	WO2002080758A2 Methods for treating drug addiction
10/17/2002	WO2002080681A1 Chimeric cell-targeting pathogenic organism and method of therapeutic use
10/17/2002	WO2002080648A2 Mucosal boosting following parenteral priming
10/17/2002	WO2002054851A3 Inhibition of pathological angiogenesis in vivo
10/17/2002	WO2002042426A3 Carrier system for specific artery wall gene delivery
10/17/2002	WO2002040700A3 Corticotropin releasing factor receptor 2 deficient mice and uses thereof
10/17/2002	WO2002040665A3 Complementing cell lines
10/17/2002	WO2002036733A9 Cd36 as a heat shock protein receptor and uses thereof
10/17/2002	WO2002036108A3 Use of 20-hete synthesizing enzyme inhibitors as therapy for cerebral vascular diseases
10/17/2002	WO2002026824A3 A novel human g-protein coupled receptor, hgprbmy5, expressed highly in brain and ovarian tissues
10/17/2002	WO2002017891A3 Method for diagnosing neuronal diseases and for treating primary hemostasis deficiency
10/17/2002	WO2002015920A3 Treatment of hyperproliferative diseases
10/17/2002	WO2002007775A3 Fusion protein for inhibition of lipoprotein secretion
10/17/2002	WO2002002148A3 Dual recombinant gene therapy compositions and methods of use
10/17/2002	WO2002000871A3 Method for introducing nucleic acids and other biologically active molecules into the nucleus of higher eukaryotic cells by means of an electrical current
10/17/2002	WO2001098344A3 Angiogenesis-modulating compositions and uses
10/17/2002	WO2001077378A3 Diagnosis of diseases associated with dna adducts
10/17/2002	WO2001074404A3 Compositions containing genetically modified lung cancer cells expressing a tgf-beta inhibitor
10/17/2002	WO2001060847A9 Avirulent, immunogenic flavivirus chimeras
10/17/2002	WO2001059094A9 Method of regulating transcription in a cell by altering remodeling of cromatin
10/17/2002	WO2001055410A9 Ceramidase compositions and methods based thereon
10/17/2002	WO2001055370A9 MODULATION OF OLIGONUCLEOTIDE CpG-MEDIATED IMMUNE STIMULATION BY POSITIONAL MODIFICATION OF NUCLEOSIDES
10/17/2002	WO2001054712A9 Compositions and methods for the early diagnosis of ovarian cancer
10/17/2002	US20020152489 Transgenic organisms having tetracycline-regulated transcriptional regulatory systems
10/17/2002	US20020152487 Transgenic animal; controlling transcription factor; administering tetracyclic promoter
10/17/2002	US20020152485 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
10/17/2002	US20020152481 Genetic engineering; qualitative analysis
10/17/2002	US20020151701 Tumor suppressor proteins; mutations; diagnosis; genetic disorders
10/17/2002	US20020151698 For diagnosis, prevention, and treatment of cancer, and neurological and immune disorders
10/17/2002	US20020151695 Transforming growth factor-beta-related molecules and uses thereof
10/17/2002	US20020151680 Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins
10/17/2002	US20020151650 Multiblock biodegradable hydrogels for drug delivery and tissue treatment
10/17/2002	US20020151592 Long term administration of L-arginine, L-lysine or salts, and a polypeptide precursor which enhance the level of endogenous nitric oxide or intermediates in the NO induced relaxation pathway in the host
10/17/2002	US20020151518 Oligonucleotide mediated specific sytokine induction and reduction of tumor growth in a mammal
10/17/2002	US20020151516 Carrier:nucleic acids complexes containing nucleic acids encoding anti-angiogenic peptides and their use in gene therapy
10/17/2002	US20020151514 Genes associated with mechanical stress, expression products therefrom, and uses thereof
10/17/2002	US20020151511 Antisense oligonucleotide modulation of human MDM2 expression
10/17/2002	US20020151510 Methods and compositions for the treatment of human immunodeficiency virus infection
10/17/2002	US20020151509 Adeno-associated viral vector-mediated delivery of DNA to cells of the liver
10/17/2002	US20020151498 Medicaments that modify activity of Lipolysis Stimulated Receptor and that can be used to influence partitioning of dietary lipids between liver and peripheral tissues, including adipose tissue
10/17/2002	US20020151496 Treatment of spinal cord damage, spinal cord trauma, neuronal tissue damage produced by ischemic attack
10/17/2002	US20020151494 Novel amino acid sequences for human semaphorin-like polypeptides
10/17/2002	US20020151485 Methods and compositions for modulating fertility
10/17/2002	US20020151484 SID nucleic acids and polypeptides selected from a pathogenic strain of hepatitis C virus and applications thereof
10/17/2002	US20020151483 C3b/C4b complement receptor-like molecules and uses thereof
10/17/2002	US20020151482 Administering to a bird or mammal a PRG-B polypeptide as an angiogenesis inhibitor; antitumor, -carcinogenic, -neoplastic and -arthritic agents; diabetic retinopathy; cancer of the lung, breast, or prostate gland; gene therapy
10/17/2002	US20020151480 Identifying a compound to treat a cardiovascular disease, e.g., atherosclerosis, characterized by aberrant 10218 nucleic acid activity or expression; detecting the presence of a nucleic acid in the sample that hybridizes to the probe
10/17/2002	US20020151478 Fusion protein comprising a latency associated peptide and a proteolytic cleavage site wherein the fusion protein is associated with a pharmaceutically active agent; gene therapy; genetic engineering; antiinflammatory agents
10/17/2002	US20020151476 An isolated and purified antiviral protein or peptide from Nostoc ellipsosporum; viricides; coupled to an effector molecule; inhibits replication of a virus, e.g. a retrovirus, in particular a human immunodeficiency virus, HIV
10/17/2002	US20020151461 Modified retinoblastoma tumor supressor proteins
10/17/2002	US20020151460 Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto
10/17/2002	US20020151070 Lipid compounds and compositions containing them which can be used for the transfer of at least one active substance, in particular a polynucleotide, into a target cell and use in gene therapy
10/17/2002	US20020151068 Compositions and methods for the diagnosis and treatment of organophosphate toxicity
10/17/2002	US20020151065 Induction of beta cell differentiation in human cells by stimulation of the GLP-1 receptor
10/17/2002	US20020151060 Generating transfection liquids; obtain nutrient broths, incubate with nucleic acids, monitor ionic mobility, store
10/17/2002	US20020151049 Self-enhancing, pharmacologically controllable expression systems
10/17/2002	US20020151032 Generation of preferential viral vector; obtain cell, incubate with viral nucleotide sequences, propagate, recover nucleotide sequences
10/17/2002	US20020151027 Viral fiber protein for use in the treatment of viral diseases
10/17/2002	US20020151022 Kinase capable of site-specific phosphorylation of IkappaBalpha
10/17/2002	US20020151021 Stimulus-inducible protein kinase complex and methods of use therefor
10/17/2002	US20020151018 Stearoyl-CoA desaturase gene promoter
10/17/2002	US20020151011 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide
10/17/2002	US20020151009 Human polynucleotides, polypeptides, and antibodies
10/17/2002	US20020150986 Extracellular matrix signalling molecules
10/17/2002	US20020150980 Nucleotide sequences coding protein for use in the treatment of asthma, parkinson's, heart, hypotension, osteporosis and urogenital disorders
10/17/2002	US20020150977 Nucleotide sequences coding protein for use in the diagnosis, treatment and prevention of autoimmune, cell proliferative and inflammatory diseases
10/17/2002	US20020150974 Polypeptide for use in the diagnosis and treatment of osteoporosis and brain disorders
10/17/2002	US20020150963 Map
10/17/2002	US20020150954 Detecting modulators of tumor suppressor gene activity; obtain cells, incubate with modulator, detec adjustment of gene expression from tumor suppressor gene, adjustment in activity indicates modulator
10/17/2002	US20020150669 Electrospraying apparatus and method for coating particles
10/17/2002	US20020150603 Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products
10/17/2002	US20020150594 Modulate immunology response
10/17/2002	US20020150591 Amplification nucleic acids
10/17/2002	US20020150586 Novel amino acid sequences, DNA encoding the amino acid sequences, antibodies directed against such sequences and the different uses thereof
10/17/2002	US20020150577 Transforming growth factor; transgenic animal; increas ratios of muscle mass
10/17/2002	US20020150566 Administering hybrid Ras proteins; anticancer agents
10/17/2002	US20020150562 Viral preparations, vectors, immunogens, and vaccines
10/17/2002	US20020150558 Immobilization; viricides
10/17/2002	US20020150557 Viricides; medical diagnosis
10/17/2002	US20020150556 Antitumor agents

1 ... 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 ... 870